Trgovina Medtronic - MDT CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.21 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.030779% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | -0.013666% | ||||||||
Čas nočne pristojbine | 22:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Medtronic PLC ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | 86.46 |
Odpri* | 86.43 |
Enoletna sprememba* | -15.2% |
Dnevni razpon* | 85.94 - 86.91 |
Razpon 52 wk | 75.77-114.31 |
Povprečni obseg (10 dni) | 5.94M |
Povprečni obseg (3 meseci) | 157.01M |
Tržna kapitalizacija | 113.38B |
Razmerje P/E | 26.47 |
Število delnic v obtoku | 1.33B |
Prihodki | 30.81B |
EPS | 3.22 |
Dividenda (donosnost v %) | 3.19099 |
Beta | 0.72 |
Datum naslednjega zaslužka | Feb 21, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Feb 7, 2023 | 86.46 | 1.53 | 1.80% | 84.93 | 86.84 | 84.93 |
Feb 6, 2023 | 85.15 | -1.49 | -1.72% | 86.64 | 86.78 | 85.12 |
Feb 3, 2023 | 86.97 | 0.47 | 0.54% | 86.50 | 87.44 | 86.42 |
Feb 2, 2023 | 87.49 | 1.96 | 2.29% | 85.53 | 87.75 | 85.53 |
Feb 1, 2023 | 85.70 | 2.02 | 2.41% | 83.68 | 86.00 | 83.13 |
Jan 31, 2023 | 83.55 | 1.29 | 1.57% | 82.26 | 83.59 | 82.26 |
Jan 30, 2023 | 82.49 | 0.20 | 0.24% | 82.29 | 82.90 | 81.95 |
Jan 27, 2023 | 82.47 | 0.69 | 0.84% | 81.78 | 83.09 | 80.67 |
Jan 26, 2023 | 81.75 | 0.26 | 0.32% | 81.49 | 81.77 | 80.90 |
Jan 25, 2023 | 81.07 | 1.26 | 1.58% | 79.81 | 81.28 | 79.74 |
Jan 24, 2023 | 80.63 | -0.67 | -0.82% | 81.30 | 82.26 | 79.96 |
Jan 23, 2023 | 82.28 | 1.64 | 2.03% | 80.64 | 82.87 | 80.64 |
Jan 20, 2023 | 80.80 | 0.86 | 1.08% | 79.94 | 80.91 | 79.20 |
Jan 19, 2023 | 79.39 | 1.16 | 1.48% | 78.23 | 79.98 | 77.75 |
Jan 18, 2023 | 78.65 | -1.51 | -1.88% | 80.16 | 80.31 | 78.58 |
Jan 17, 2023 | 80.22 | -0.32 | -0.40% | 80.54 | 80.87 | 79.31 |
Jan 13, 2023 | 80.45 | 1.47 | 1.86% | 78.98 | 80.61 | 78.79 |
Jan 12, 2023 | 79.73 | -0.26 | -0.33% | 79.99 | 80.57 | 78.78 |
Jan 11, 2023 | 80.20 | 1.03 | 1.30% | 79.17 | 80.36 | 77.93 |
Jan 10, 2023 | 78.78 | 1.35 | 1.74% | 77.43 | 79.32 | 77.43 |
Medtronic Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|---|
Skupni prihodki | 29710 | 29953 | 30557 | 28913 | 30117 | 31686 |
Prihodki | 29710 | 29953 | 30557 | 28913 | 30117 | 31686 |
Celotni stroški prihodkov | 9267 | 9039 | 9064 | 9269 | 10355 | 9971 |
Bruto dobiček | 20443 | 20914 | 21493 | 19644 | 19762 | 21715 |
Celotni odhodki iz poslovanja | 24327 | 23351 | 24774 | 24535 | 25941 | 25934 |
Celotna prodaja/splošni/upravni stroški Odhodki | 10018 | 9953 | 10232 | 9875 | 9776 | 10135 |
Raziskave in razvoj | 2193 | 2256 | 2330 | 2331 | 2493 | 2746 |
Depreciation / Amortization | 1980 | 1823 | 1764 | 1756 | 1783 | 1733 |
Odhodki (prihodki) od obresti - neto poslovanje | -54 | 226 | -224 | -117 | ||
Nenavadni odhodki (prihodki) | 630 | -172 | 1342 | 1303 | 1219 | 1154 |
Other Operating Expenses, Total | 293 | 226 | 266 | 118 | 315 | 195 |
Prihodki iz poslovanja | 5383 | 6602 | 5783 | 4378 | 4176 | 5752 |
Prihodki (odhodki) od obresti, neto Neoperativni | -728 | -938 | -676 | -379 | -425 | -541 |
Drugo, neto | -53 | 11 | 90 | 56 | 144 | 306 |
Čisti dobiček pred obdavčitvijo | 4602 | 5675 | 5197 | 4055 | 3895 | 5517 |
Čisti dobiček po davkih | 4024 | 5377 | 4662 | 4743 | 3524 | 5061 |
Manjšinski delež | 4 | 9 | -19 | -17 | -24 | -22 |
Čisti dobiček pred dodatnimi postavkami | 4028 | 5386 | 4643 | 4726 | 3500 | 5039 |
Čisti dobiček | 4028 | 3104 | 4631 | 4789 | 3606 | 5039 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 4028 | 5386 | 4643 | 4726 | 3500 | 5039 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 4028 | 3104 | 4631 | 4789 | 3606 | 5039 |
Popravljen čisti dobiček | 4028 | 3104 | 4631 | 4789 | 3606 | 5039 |
Popravljene ponderirane povprečne delnice | 1391.4 | 1368.2 | 1357.5 | 1351.1 | 1354 | 1351.4 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 2.89493 | 3.93656 | 3.42026 | 3.49789 | 2.58493 | 3.72873 |
Dividends per Share - Common Stock Primary Issue | 1.72 | 1.84 | 2 | 2.16 | 2.32 | 2.52 |
Popravljen normalizirani dobiček na enoto čistega dobička | 3.43538 | 3.82352 | 4.31147 | 4.13123 | 3.55835 | 4.58931 |
Skupaj izredne postavke | -2282 | -12 | 63 | 106 | ||
Total Adjustments to Net Income | 0 |
Q4 2021 | Q1 2021 | Q2 2021 | Q3 2022 | Q4 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 8188 | 7987 | 7847 | 7763 | 8089 |
Prihodki | 8188 | 7987 | 7847 | 7763 | 8089 |
Celotni stroški prihodkov | 2620 | 2507 | 2466 | 2433 | 2565 |
Bruto dobiček | 5568 | 5480 | 5381 | 5330 | 5524 |
Celotni odhodki iz poslovanja | 6583 | 7128 | 6284 | 6104 | 6418 |
Celotna prodaja/splošni/upravni stroški Odhodki | 2348 | 2510 | 2579 | 2521 | 2570 |
Raziskave in razvoj | 632 | 750 | 676 | 668 | 652 |
Depreciation / Amortization | 446 | 436 | 431 | 432 | 435 |
Nenavadni odhodki (prihodki) | 338 | 833 | 111 | 113 | 53 |
Other Operating Expenses, Total | 199 | 92 | 21 | -63 | 143 |
Prihodki iz poslovanja | 1605 | 859 | 1563 | 1659 | 1671 |
Prihodki (odhodki) od obresti, neto Neoperativni | -94 | -51 | -86 | -103 | -167 |
Drugo, neto | 55 | 25 | 16 | 33 | 98 |
Čisti dobiček pred obdavčitvijo | 1566 | 833 | 1493 | 1589 | 1602 |
Čisti dobiček po davkih | 1366 | 769 | 1317 | 1483 | 1492 |
Manjšinski delež | -6 | -6 | -6 | -4 | -6 |
Čisti dobiček pred dodatnimi postavkami | 1360 | 763 | 1311 | 1479 | 1486 |
Čisti dobiček | 1360 | 763 | 1311 | 1479 | 1486 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 1360 | 763 | 1311 | 1480 | 1485 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 1360 | 763 | 1311 | 1480 | 1485 |
Popravljen čisti dobiček | 1360 | 763 | 1311 | 1480 | 1485 |
Popravljene ponderirane povprečne delnice | 1357.9 | 1344.5 | 1355.3 | 1350.3 | 1343.9 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 1.00155 | 0.5675 | 0.96731 | 1.09605 | 1.10499 |
Dividends per Share - Common Stock Primary Issue | 0.58 | 0.63 | 0.63 | 0.63 | 0.63 |
Popravljen normalizirani dobiček na enoto čistega dobička | 1.38596 | 1.32317 | 1.06914 | 1.11753 | 1.05737 |
Total Adjustments to Net Income | 1 | -1 |
- Letni
- Četrtletno
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 24873 | 22980 | 21967 | 22031 | 22548 | 23059 |
Denarna sredstva in kratkoročne naložbe | 13708 | 11227 | 9848 | 10948 | 10817 | 10573 |
Denarna sredstva in ustrezniki | 4967 | 3669 | 4393 | 4140 | 3593 | 3714 |
Kratkoročne naložbe | 8741 | 7558 | 5455 | 6808 | 7224 | 6859 |
Celotne terjatve, neto | 5591 | 5987 | 6222 | 4645 | 5462 | 5551 |
Accounts Receivable - Trade, Net | 5591 | 5987 | 6222 | 4645 | 5462 | 5551 |
Total Inventory | 3338 | 3579 | 3753 | 4229 | 4313 | 4616 |
Other Current Assets, Total | 2236 | 2187 | 2144 | 2209 | 1956 | 2319 |
Total Assets | 99857 | 91393 | 89694 | 90689 | 93083 | 90981 |
Property/Plant/Equipment, Total - Net | 4361 | 4604 | 4675 | 5755 | 6219 | 6267 |
Property/Plant/Equipment, Total - Gross | 9691 | 10259 | 10920 | 12571 | 13698 | 14219 |
Accumulated Depreciation, Total | -5330 | -5655 | -6245 | -6816 | -7479 | -7952 |
Goodwill, Net | 38515 | 39543 | 39959 | 39841 | 41961 | 40502 |
Intangibles, Net | 23407 | 21723 | 20560 | 19063 | 17740 | 15595 |
Long Term Investments | 692 | 515 | 372 | 480 | 687 | 881 |
Other Long Term Assets, Total | 8009 | 2028 | 2161 | 3519 | 3928 | 4677 |
Total Current Liabilities | 14264 | 10084 | 8472 | 10366 | 8509 | 12394 |
Accounts Payable | 1555 | 1628 | 1953 | 1996 | 2106 | 2276 |
Accrued Expenses | 4443 | 5232 | 4885 | 4839 | 5681 | 5367 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7520 | 2058 | 838 | 2776 | 11 | 3742 |
Other Current Liabilities, Total | 746 | 1166 | 796 | 755 | 711 | 1009 |
Total Liabilities | 49649 | 40673 | 39603 | 39952 | 41655 | 38430 |
Total Long Term Debt | 25921 | 23699 | 24486 | 22021 | 26378 | 20372 |
Long Term Debt | 25898 | 23678 | 24476 | 21976 | 26316 | 20316 |
Capital Lease Obligations | 23 | 21 | 10 | 45 | 62 | 56 |
Deferred Income Tax | 2978 | 1423 | 1278 | 1174 | 1028 | 884 |
Minority Interest | 122 | 102 | 121 | 135 | 174 | 171 |
Other Liabilities, Total | 6364 | 5365 | 5246 | 6256 | 5566 | 4609 |
Total Equity | 50208 | 50720 | 50091 | 50737 | 51428 | 52551 |
Common Stock | 0 | 0 | 0.13407 | 0.13411 | 0.13454 | 0.13307 |
Additional Paid-In Capital | 29551 | 28127 | 26532 | 26165 | 26319 | 24566 |
Retained Earnings (Accumulated Deficit) | 23270 | 24379 | 26270 | 28132 | 28594 | 30250 |
Unrealized Gain (Loss) | -69 | -194 | -45 | 0 | 92 | -209 |
Other Equity, Total | -2544 | -1592 | -2666.13 | -3560.13 | -3577.13 | -2056.13 |
Total Liabilities & Shareholders’ Equity | 99857 | 91393 | 89694 | 90689 | 93083 | 90981 |
Total Common Shares Outstanding | 1369.42 | 1354.22 | 1340.7 | 1341.07 | 1345.4 | 1330.74 |
Apr 2021 | Jul 2021 | Oct 2021 | Jan 2022 | Apr 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 22548 | 22434 | 22731 | 23303 | 23059 |
Denarna sredstva in kratkoročne naložbe | 10817 | 10595 | 10669 | 11221 | 10573 |
Denarna sredstva in ustrezniki | 3593 | 3004 | 2900 | 3479 | 3714 |
Kratkoročne naložbe | 7224 | 7591 | 7769 | 7742 | 6859 |
Celotne terjatve, neto | 5462 | 5431 | 5493 | 5446 | 5551 |
Accounts Receivable - Trade, Net | 5462 | 5431 | 5493 | 5446 | 5551 |
Total Inventory | 4313 | 4288 | 4349 | 4514 | 4616 |
Other Current Assets, Total | 1956 | 2120 | 2220 | 2122 | 2319 |
Total Assets | 93083 | 91802 | 91756 | 91804 | 90981 |
Property/Plant/Equipment, Total - Net | 6219 | 5162 | 5188 | 5251 | 5413 |
Property/Plant/Equipment, Total - Gross | 12700 | 12808 | 12978 | 13074 | 13365 |
Accumulated Depreciation, Total | -7479 | -7646 | -7790 | -7823 | -7952 |
Goodwill, Net | 41961 | 41720 | 41612 | 41346 | 40502 |
Intangibles, Net | 17740 | 16890 | 16523 | 16078 | 15595 |
Long Term Investments | 687 | 692 | 781 | 827 | 881 |
Other Long Term Assets, Total | 3928 | 4904 | 4921 | 4999 | 5531 |
Total Current Liabilities | 8509 | 7764 | 7803 | 8927 | 12394 |
Accounts Payable | 2106 | 1864 | 1917 | 1985 | 2276 |
Accrued Expenses | 5681 | 5553 | 5403 | 5694 | 5672 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 11 | 6 | 16 | 865 | 3742 |
Other Current Liabilities, Total | 711 | 341 | 467 | 383 | 704 |
Total Liabilities | 41655 | 40316 | 39765 | 39262 | 38430 |
Total Long Term Debt | 26378 | 25958 | 25607 | 24290 | 20372 |
Long Term Debt | 26316 | 25898 | 25548 | 24232 | 20316 |
Capital Lease Obligations | 62 | 60 | 59 | 58 | 56 |
Deferred Income Tax | 1028 | 1054 | 1024 | 968 | 884 |
Minority Interest | 174 | 178 | 168 | 171 | 171 |
Other Liabilities, Total | 5566 | 5362 | 5163 | 4906 | 4609 |
Total Equity | 51428 | 51486 | 51991 | 52542 | 52551 |
Common Stock | 0.13454 | 0.13447 | 0.13449 | 0.13426 | 0.13307 |
Additional Paid-In Capital | 26319 | 26184 | 26059 | 25814 | 24566 |
Retained Earnings (Accumulated Deficit) | 28594 | 28511 | 28974 | 29607 | 30250 |
Unrealized Gain (Loss) | 92 | 104 | 48 | -22 | -209 |
Other Equity, Total | -3577.13 | -3313.13 | -3090.13 | -2857.13 | -2056.13 |
Total Liabilities & Shareholders’ Equity | 93083 | 91802 | 91756 | 91804 | 90981 |
Total Common Shares Outstanding | 1345.4 | 1344.67 | 1344.86 | 1342.57 | 1330.74 |
- Letni
- Četrtletno
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|---|
Čisti prihodki/začetna postavka | 4024 | 3095 | 4650 | 4806 | 3630 | 5062 |
Denarna sredstva iz poslovanja | 6880 | 4684 | 7007 | 7234 | 6240 | 7347 |
Denarna sredstva iz poslovanja | 2917 | 2644 | 2659 | 2663 | 2702 | 2707 |
Deferred Taxes | -459 | -919 | -304 | -1315 | -422 | -604 |
Nedenarne postavke | 259 | 37 | 1082 | 1019 | 1031 | 1070 |
Cash Taxes Paid | 1029 | 2542 | 1558 | 878 | 1250 | 996 |
Denarna sredstva Plačane obresti | 1134 | 1147 | 973 | 643 | 582 | 540 |
Spremembe v obratnem kapitalu | 139 | -173 | -1080 | 61 | -701 | -888 |
Denarna sredstva pri naložbenju | -1571 | 5858 | -774 | -3203 | -2866 | -1659 |
Kapitalski izdatki | -1254 | -1068 | -1134 | -1213 | -1355 | -1368 |
Celotne druge postavke denarnih tokov pri naložbenju | -317 | 6926 | 360 | -1990 | -1511 | -291 |
Denarna sredstva pri financiranju | -3283 | -11954 | -5431 | -4198 | -4136 | -5336 |
Postavke denarnega toka pri financiranju | 16 | -50 | 14 | -81 | -268 | 163 |
Total Cash Dividends Paid | -2376 | -2494 | -2693 | -2894 | -3120 | -3383 |
Izdaja (odplačilo) delnic, neto | -3116 | -1768 | -1885 | -664 | -178 | -2115 |
Izdaja (odplačilo) dolga, neto | 2193 | -7642 | -867 | -559 | -570 | -1 |
Učinki deviznih tečajev | 65 | 114 | -78 | -86 | 215 | -231 |
Neto sprememba denarnih sredstev | 2091 | -1298 | 724 | -253 | -547 | 121 |
Apr 2021 | Jul 2021 | Oct 2021 | Jan 2022 | Apr 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 3630 | 769 | 2086 | 3570 | 5062 |
Cash From Operating Activities | 6240 | 1292 | 3061 | 5289 | 7347 |
Cash From Operating Activities | 2702 | 671 | 1347 | 2019 | 2707 |
Deferred Taxes | -422 | -11 | -78 | -234 | -604 |
Non-Cash Items | 1031 | 715 | 888 | 943 | 1070 |
Cash Taxes Paid | 1250 | 249 | 615 | 842 | 996 |
Cash Interest Paid | 582 | 63 | 280 | 295 | 540 |
Changes in Working Capital | -701 | -852 | -1182 | -1009 | -888 |
Cash From Investing Activities | -2866 | -784 | -1493 | -1930 | -1659 |
Capital Expenditures | -1355 | -378 | -649 | -979 | -1368 |
Other Investing Cash Flow Items, Total | -1511 | -406 | -844 | -951 | -291 |
Cash From Financing Activities | -4136 | -1055 | -2210 | -3387 | -5336 |
Financing Cash Flow Items | -268 | -4 | -46 | -52 | 163 |
Total Cash Dividends Paid | -3120 | -846 | -1693 | -2540 | -3383 |
Issuance (Retirement) of Stock, Net | -178 | -204 | -470 | -794 | -2115 |
Issuance (Retirement) of Debt, Net | -570 | -1 | -1 | -1 | -1 |
Foreign Exchange Effects | 215 | -42 | -51 | -87 | -231 |
Net Change in Cash | -547 | -589 | -693 | -115 | 121 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.2656 | 123248662 | 1047118 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.2175 | 69402209 | 2827542 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.4347 | 58989713 | 928929 | 2022-09-30 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 2.4586 | 32704032 | -3310577 | 2022-09-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.3378 | 31097310 | -1528322 | 2022-09-30 | LOW |
Capital Research Global Investors | Investment Advisor | 2.1634 | 28777470 | 2742283 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.0147 | 26798585 | 266802 | 2022-09-30 | LOW |
Managed Account Advisors LLC | Investment Advisor | 1.3821 | 18384675 | 1323622 | 2022-09-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.1369 | 15122818 | 1678374 | 2022-09-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.1083 | 14742019 | 2210763 | 2022-09-30 | LOW |
Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 1.0461 | 13914717 | -2233182 | 2022-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9805 | 13042271 | -297020 | 2021-12-31 | LOW |
Sanders Capital, LLC | Investment Advisor | 0.9666 | 12857710 | 216664 | 2022-09-30 | LOW |
Wells Fargo Advisors | Research Firm | 0.9062 | 12053796 | 275747 | 2022-09-30 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.862 | 11466061 | 195013 | 2022-09-30 | LOW |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.8604 | 11444919 | 371813 | 2022-09-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 0.77 | 10242221 | -1191564 | 2022-09-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7576 | 10077987 | -322973 | 2022-09-30 | LOW |
AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 0.7398 | 9840128 | 870079 | 2022-09-30 | LOW |
Aristotle Capital Management, LLC | Investment Advisor | 0.7244 | 9635239 | -57036 | 2022-09-30 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com GroupBorzni posredniki
Aktivne stranke mesečno
Mesečni obseg naložb
Dvigi vsak mesec
Kalkulator trgovanja
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Medtronic Company profile
O družbi Medtronic
Medtronic plc je globalno podjetje za zdravstveno tehnologijo. Razvija, proizvaja in trži medicinske pripomočke in tehnologije za bolnišnice, zdravnike, zdravnike in bolnike. Njegovi poslovni segmenti so kardiovaskularni, medicinsko-kirurški, nevroznanstveni in diabetološki. Kardiovaskularni izdelki vključujejo srčne spodbujevalnike, vstavljive srčne monitorje in naprave za resinhronizacijsko zdravljenje srca. Medicinsko-kirurški izdelki vključujejo oskrbo bolnikov od diagnoze do okrevanja s poudarkom na boleznih prebavil, pljuč, medenice, ledvic, debelosti in zapletih, ki jih je mogoče preprečiti. Nevrološki izdelki vključujejo različne hrbtenične vsadke, nadomestke za kostne presadke, biološke izdelke, slikovno vodeno kirurgijo in intraoperativne slikovne sisteme. Izdelki za sladkorno bolezen vključujejo inzulinske črpalke, sisteme za neprekinjeno spremljanje glukoze (CGM), potrošni material in sisteme pametnih inzulinskih peres. Podjetje ponuja tudi izdelke PROPEL in SINUVA, ki so bioabsorpcijski vsadki za bolnike s sinusi, pri katerih se sproščajo steroidi.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
20 On Hatch
Hatch Street Lower
DUBLIN
DUBLIN
IE
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com